Clinical trial Recruiting at 2 sites Observational Ages 15 and up

Normal ranges for knee rotation in competitive pivot-sport athletes

Official title: Reference Values for Knee Rotational Amplitudes in a Population of Athletes

Run by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · NCT07013019 · Data updated 2026-11-12

This project will measure overall knee rotation in healthy competitive pivot-sport athletes aged 15 and older to establish normal reference values.

More Anterior Cruciate Ligament Injury trials

Quick facts

Study typeObservational
Ages15 Years and up
SexAll
Enrollment482 (estimated)
SponsorCentre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Academic / other
Locations2 sites (Toulon, Var and 1 other locations)
StatusRecruiting
StartedJune 6, 2025
Main results expectedOctober 2026
Study endsOctober 2026
Registry record updatedJuly 7, 2026
Trial IDNCT07013019 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy competitive pivot-sport athletes aged 15 years and older with no history of knee injury or knee surgery are ideal candidates.

Probably not a fit

People with previous knee ligament/meniscus/cartilage/bone injuries, current knee pain or instability, prior knee surgery, systemic musculoskeletal disease, or non-pivot-sport participants are unlikely to benefit from this reference-data project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter observational effort combining retrospective and prospective data collection at two French sports medicine centers between 2022 and 2026. Healthy male and female athletes aged 15+ who compete in pivot sports will have overall (internal + external) knee rotational amplitudes measured using standardized clinical/dynamic arthrometer methods. Participants with prior knee ligament, meniscus, cartilage or bone injuries, current knee symptoms, or prior knee surgery are excluded. The goal is to define normative rotation ranges to help distinguish natural laxity from pathology.

Why it matters

Potential benefit: If successful, clinicians will have validated reference values for knee rotation to help recognize abnormal rotational laxity after ACL injury and guide diagnosis and rehabilitation.

How similar studies have gone: Previous research indicates the ACL significantly controls tibial rotation and that rotation increases after rupture, but comprehensive normative rotation ranges specifically in competitive pivot-sport athletes remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Athletes with healthy knees, men and women ;
2. Age greater than or equal to 15 years;
3. Competitive pivot sports.

Exclusion Criteria:

1. History of ligament, meniscus, cartilage or bone lesions in the knee ;
2. Pain, stiffness or instability in the knee at the time of inclusion;
3. Knee surgery, including ligament reconstruction;
4. Systemic diseases or medical conditions that may affect the musculoskeletal system;
5. Opposition of the participant and/or his/her legal representative in the case of a minor participant;
6. Participant under protective supervision.

Where it's running

  • Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
    Toulon, Var, France
    Recruiting
  • Centre de Médecine du Sport
    Brest, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.